Stephen K. Doberstein - Sep 19, 2023 Form 4 Insider Report for Forte Biosciences, Inc. (FBRX)

Role
Director
Signature
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
Stock symbol
FBRX
Transactions as of
Sep 19, 2023
Transactions value $
$0
Form type
4
Date filed
9/20/2023, 05:48 PM
Previous filing
Jun 2, 2022
Next filing
Aug 22, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FBRX Stock Option (right to buy) Award $0 +25K $0.00 25K Sep 19, 2023 Common Stock 25K $0.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting. "Date of Grant" shall mean September 19, 2023.